| Patents for C07K - Peptides (3,738) |
|---|
| 05/12/2005 | WO2004104022A3 Compositions comprising pathogen elicited epithelial chemoattractant (eicosanoid hepoxilin a3), inhibitors thereof and methods of use thereof |
| 05/12/2005 | CA2543930A1 New coupling agents for peptide synthesis |
| 05/12/2005 | CA2528370A1 Capture and release based isotope tagged peptides and methods for using the same |
| 05/11/2005 | EP1248802B9 Soluble ctla4 mutant molecules and uses thereof |
| 05/06/2005 | WO2005040196A2 Pif peptides biologic activities, site of action, and the antibody to detect pif |
| 05/06/2005 | WO2005040195A2 Formulation of exendins |
| 05/06/2005 | WO2005040194A2 Methods and compositions for pdgf-c activation and inhibition |
| 05/06/2005 | WO2005040193A2 Synthetic peptides that cause f-actin bundling and block actin depolymerization |
| 05/06/2005 | WO2005040191A2 Ccn1 compositions and methods |
| 05/06/2005 | WO2005023834A3 Peptides and compounds that bind to thrombopoietin receptors |
| 05/06/2005 | WO2005019240A3 Melanin concentrating hormone receptor antagonists |
| 05/06/2005 | WO2004104018A3 Compositions for delivering peptide yy and pyy agonists |
| 05/06/2005 | WO2004078776A3 Ny-eso-1 peptides which bind to class ii molecules and uses thereof |
| 05/06/2005 | CA2584690A1 Pif peptides biologic activities, site of action, and the antibody to detect pif |
| 05/05/2005 | US20050095649 Affinity capture of peptides by microarray and related methods |
| 04/28/2005 | WO2005037858A2 Template-directed assembly of receptor signaling complexes |
| 04/28/2005 | WO2005037857A2 Method of protein analysis by maldi using protein fragmentation with peroxycarbonates |
| 04/28/2005 | WO2005037856A2 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
| 04/28/2005 | WO2005037855A2 T cell epitopes useful in a yersinia pestis vaccine and as diagnostic tools and methods for identifying same |
| 04/28/2005 | WO2005037854A2 Immunogenic peptides |
| 04/28/2005 | WO2005037853A2 Side chain deuterated amino acids and methods of use |
| 04/28/2005 | WO2004096832A3 Novel antiangiogenic peptides |
| 04/28/2005 | WO2004078775A3 Intracellular signaling-induced ret-independent gdnf receptor-effected morphological changes |
| 04/28/2005 | WO2004041846A3 INDUCIBLE LIGAND FOR α1β1 INTEGRIN AND USES |
| 04/28/2005 | US20050090432 Macrocyclic isoquinoline peptide inhibitors of Hepatitis C virus |
| 04/28/2005 | US20050089526 Monomeric unit of the complex containin HIV-1 gp120 and HIV-1 gp41, (ii) the gp4l has one or more mutations in its N-terminal helix, and (iii) the gp120 and gp41 are bound to each other by a disulfide bond between a cysteine residue introduced into the gp120 and a cysteine residue introduced into gp41 |
| 04/28/2005 | CA2542674A1 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
| 04/27/2005 | CN1198936C Alzheimer's disease secretase |
| 04/27/2005 | CN1198841C Method for preparing cyclic vasoactive peptide analogs |
| 04/21/2005 | WO2005035552A2 Transducing combinatorial peptide library |
| 04/21/2005 | WO2005035551A2 Inhibitors of proteins that bind phosphorylated molecules |
| 04/21/2005 | WO2005035550A2 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier |
| 04/21/2005 | WO2005007677A3 Affinity capture of peptides by microarray and related methods |
| 04/21/2005 | WO2004072104A3 Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon |
| 04/21/2005 | US20050084491 Use as an immunogen to generate anti-integrin antibodies; a mimotope; vaccinating against angiogenic and metastatic diseases |
| 04/20/2005 | CN1608079A Chemically-modified human growth hormone conjugates |
| 04/14/2005 | WO2005033125A2 Mammalian t1r3 sweet taste receptors |
| 04/14/2005 | WO2005033124A1 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1) |
| 04/14/2005 | WO2004087732A3 Process for the preparation of (1s, 4s)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-naphthylamine |
| 04/14/2005 | WO2004072105A3 Iap-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods |
| 04/14/2005 | WO2004046168A3 Recombinant hiv-1 subclass d envelope glycoproteins |
| 04/14/2005 | WO2004011485A3 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 04/14/2005 | US20050079549 Methods for modeling GPCRs and for producing ligand blocking and receptor activating antibodies for same |
| 04/14/2005 | US20050079184 Antiinflammatory agents; anticancer agents; neurodegenerative disease; autoimmune diseases ; skin disorders; antiarthritic agents; Alzheimer's disease; antidiabetic agents |
| 04/14/2005 | CA2540837A1 Mammalian t1r3 sweet taste receptors |
| 04/13/2005 | EP1521587A2 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells |
| 04/13/2005 | CN1196714C Process for producing immunolobulins for intravenous administration and other immunolobulin products |
| 04/12/2005 | CA2203936C Boronic ester and acid compounds, synthesis and uses |
| 04/07/2005 | WO2005030793A2 Antibodies which bind human cxcr3 |
| 04/07/2005 | WO2005030792A2 Quinoline potassium channel inhibitors |
| 04/07/2005 | WO2005030791A2 Isoquinolinone potassium channel inhibitors |
| 04/07/2005 | WO2005010024A3 Potent peptide inhibitors and methods of use |
| 04/07/2005 | WO2005007678A3 Methods for the preparation of rhodamine |
| 04/07/2005 | WO2005007676A3 Glycopeptides for the treatment of als and other metabolic and autoimmune disorders |
| 04/07/2005 | WO2004081033A3 Synthesis of proteins by cell-free protein expression |
| 04/07/2005 | WO2004074313A3 Methods for prediction of amyloid fibril formation and identification of peptides useful as therapeutic and diagnostic agents |
| 04/07/2005 | US20050074485 Anti-inflammatory/anti-microbial peptides for use in dialysis |
| 03/31/2005 | WO2005028499A2 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom |
| 03/31/2005 | WO2005028498A2 Kid3 and kid3 antibodies that bind thereto |
| 03/31/2005 | WO2005028496A2 Vaccine for treatment and prevention of herpes simplex virus infection |
| 03/31/2005 | WO2004087736A3 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip) |
| 03/31/2005 | CA2539437A1 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom |
| 03/31/2005 | CA2539322A1 Kid3 and kid3 antibodies that bind thereto |
| 03/31/2005 | CA2538794A1 Vaccine for treatment and prevention of herpes simplex virus infection |
| 03/30/2005 | EP1517710A1 Pegylated factor vii glycoforms |
| 03/30/2005 | CN1602316A Flavivirus NS1 subunit vaccine |
| 03/24/2005 | WO2005026194A2 Granulysin peptides and methods of use thereof |
| 03/24/2005 | WO2005026193A2 Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof |
| 03/24/2005 | WO2005026192A2 Hpv cd8+ t-cell epitopes |
| 03/24/2005 | WO2005026191A2 Size-controlled macromolecule |
| 03/24/2005 | WO2005025497A2 Hpv cd8+ t-cell epitopes |
| 03/24/2005 | WO2005005456A3 Peptide deformylase inhibitors |
| 03/24/2005 | WO2004111074A9 In vivo production of a clostridial neurotoxin light chain peptide |
| 03/24/2005 | WO2004108747A3 Lectin conjugates |
| 03/24/2005 | WO2004072101A3 Phenylglycine derivatives useful as serine protease inhibitors |
| 03/24/2005 | WO2004072097A3 A microchip-based system for hiv diagnostics |
| 03/24/2005 | WO2004071387A3 Hsp60 from arthrobacter |
| 03/24/2005 | WO2004069860A3 Isg15-conjugated proteins |
| 03/24/2005 | WO2004067554A3 Compositions and methods of tolerizing a primate to an antigen |
| 03/24/2005 | WO2004065409A3 Peptide mimotopes of lipooligosaccharide from nontypeable haemophilus influenzae as vaccines |
| 03/24/2005 | US20050065072 Bactericides; immobilized |
| 03/24/2005 | US20050064511 Polypeptides related to natriuretic peptides and methods of their identification and use |
| 03/24/2005 | US20050063970 An immunomolecule containing a soluble human Major Histocompatibility Complex class I effector domain linked to an antibody targeting domain; immunotherapy; anticarcinogenic agents |
| 03/24/2005 | CA2536735A1 Methods for determining cd8+ t-cell epitopes |
| 03/17/2005 | WO2005023837A2 Ebola peptides and immunogenic compositions containing same |
| 03/17/2005 | WO2005023834A2 Peptides and compounds that bind to thrombopoietin receptors |
| 03/17/2005 | WO2004092196A3 Tie-2 modulators and methods of use |
| 03/17/2005 | WO2004092194A3 Chimeric polypeptides and their use |
| 03/17/2005 | WO2004087737A3 Omega-3 fatty acid assays for disease risk assessment |
| 03/17/2005 | WO2004076473A3 Androgen receptor interacting peptides |
| 03/17/2005 | WO2004072098A3 Immunocompromised rodents as dual color tumor models |
| 03/17/2005 | US20050059593 From Vibrio cholerae phage; cadherins; immunogens; drug screening; for treatment of autoimmune and gastrointestinal diseases, food allergies, and Celiac disease; vaccines; antibodies |
| 03/17/2005 | US20050059089 Complexes of GPCR142 and relaxin3 or INSL5, and their production and use |
| 03/17/2005 | CA2517264A1 Ebola peptides and immunogenic compositions containing same |
| 03/16/2005 | EP0907737B1 Il-6 mutein |
| 03/16/2005 | EP0869966B1 Prodrugs of thrombin inhibitors |
| 03/10/2005 | WO2005021583A2 METHODS FOR IDENTIFYING, TREATING, AND INDUCING INFERTILITY USING SMC1β |
| 03/10/2005 | WO2005021581A2 Inducers of plant disease resistance |
| 03/10/2005 | WO2005021580A2 Hydrogels for modulating cell migration and matrix deposition |
| 03/10/2005 | WO2005021579A2 Epo mimetic peptides and fusion proteins |